AFP
LLY icon

Ausdal Financial Partners’s Eli Lilly LLY Stock Holding History

Ausdal Financial Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.35M Sell
6,901
-958
-12% -$971K 0.28% 88
2025
Q4 		$8.45M Buy
7,859
+1,507
+24% +$1.44M 0.39% 54
2025
Q3 		$4.85M Buy
6,352
+1,881
+42% +$1.4M 0.24% 103
2025
Q2 		$3.49M Buy
4,471
+223
+5% +$173K 0.23% 107
2025
Q1 		$3.51M Buy
4,248
+459
+12% +$382K 0.26% 93
2024
Q4 		$2.93M Buy
3,789
+392
+12% +$325K 0.25% 98
2024
Q3 		$3.01M Buy
3,397
+255
+8% +$229K 0.31% 80
2024
Q2 		$2.84M Sell
3,142
-135
-4% -$108K 0.3% 79
2024
Q1 		$2.55M Buy
3,277
+29
+0.9% +$20.6K 0.3% 84
2023
Q4 		$1.89M Buy
3,248
+176
+6% +$103K 0.23% 103
2023
Q3 		$1.65M Sell
3,072
-86
-3% -$44.3K 0.23% 108
2023
Q2 		$1.48M Buy
3,158
+175
+6% +$73.4K 0.2% 119
2023
Q1 		$1.02M Sell
2,983
-110
-4% -$37.1K 0.14% 163
2022
Q4 		$1.13M Buy
3,093
+679
+28% +$241K 0.16% 148
2022
Q3 		$781K Buy
2,414
+97
+4% +$30.7K 0.12% 188
2022
Q2 		$751K Hold
2,317
– – 0.11% 209
2022
Q1 		$663K Buy
2,317
+301
+15% +$77.5K 0.09% 229
2021
Q4 		$557K Sell
2,016
-90
-4% -$22.8K 0.07% 263
2021
Q3 		$487K Sell
2,106
-136
-6% -$33.6K 0.07% 271
2021
Q2 		$515K Sell
2,242
-269
-11% -$54K 0.08% 258
2021
Q1 		$469K Buy
2,511
+241
+11% +$47.1K 0.08% 254
2020
Q4 		$383K Buy
2,270
+193
+9% +$28.8K 0.07% 266
2020
Q3 		$307K Buy
2,077
+207
+11% +$32K 0.07% 255
2020
Q2 		$307K Hold
1,870
– – 0.1% 198
2020
Q1 		$295K Sell
1,870
-375
-17% -$51.5K 0.1% 193
2019
Q4 		$314K Sell
2,245
-319
-12% -$37K 0.09% 242
2019
Q3 		$287K Hold
2,564
– – 0.1% 235
2019
Q2 		$279K Buy
2,564
+230
+10% +$27.1K 0.11% 221
2019
Q1 		$303K Sell
2,334
-287
-11% -$34.9K 0.12% 198
2018
Q4 		$303K Sell
2,621
-616
-19% -$68.8K 0.15% 168
2018
Q3 		$347K Buy
3,237
+69
+2% +$6.9K 0.1% 250
2018
Q2 		$270K Sell
3,168
-425
-12% -$34.9K 0.08% 297
2018
Q1 		$278K Buy
3,593
+544
+18% +$43.8K 0.1% 264
2017
Q4 		$258K Buy
3,049
+1
+0% +$85 0.09% 286
2017
Q3 		$261K Buy
3,048
+331
+12% +$27.1K 0.1% 257
2017
Q2 		$224K Sell
2,717
-396
-13% -$32.3K 0.1% 267
2017
Q1 		$262K Buy
3,113
+206
+7% +$16.5K 0.12% 216
2016
Q4 		$214K Buy
2,907
+4
+0.1% +$298 0.1% 229
2016
Q3 		$233K Sell
2,903
-80
-3% -$6.4K 0.12% 212
2016
Q2 		$235K Buy
2,983
+126
+4% +$9.49K 0.12% 199
2016
Q1 		$206K Sell
2,857
-521
-15% -$39.4K 0.12% 199
2015
Q4 		$285K Buy
+3,378
New +$280K 0.14% 162

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ausdal Financial Partners's LLY Position: Q1 2026 in Review

Ausdal Financial Partners reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $971K and leaving 6,901 shares worth $6.35M. The position accounts for 0.28% of the portfolio, ranked #88.

Ausdal Financial Partners first reported a position in LLY in Q4 2015 and has held it in 42 quarters since. The position peaked at $8.45M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ausdal Financial Partners held 6,901 shares of Eli Lilly worth $6.35M as of Q1 2026.
  • Ausdal Financial Partners sold 958 Eli Lilly shares in Q1 2026, an estimated $971K.
  • Eli Lilly made up 0.28% of Ausdal Financial Partners's portfolio in Q1 2026, its #88 holding.
  • Ausdal Financial Partners first reported a position in Eli Lilly in Q4 2015 and has held it in 42 quarters since.
  • Ausdal Financial Partners's Eli Lilly position peaked at $8.45M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.